Blood Pressure Clinical Trial
Official title:
Protective Assets Reinforced With Integrated Care and TechnologY (PARITY) Feasibility Trial
This study will determine the feasibility and acceptability of the Protective Assets Reinforced with Integrated care and TechnologY (PARITY) program, to test the clinical, behavioral, and strength building efficacy of the PARITY program and explore how it achieves its outcomes in pregnant Black women. PARITY is a program that provides community-based doula support, community resources, and a mobile technology platform that reinforces individual strengths (referred to as protective assets) through positive messaging and by promoting wellness.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | October 31, 2024 |
Est. primary completion date | April 29, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 19 Years to 51 Years |
Eligibility | Inclusion Criteria: - Black race - Pregnant with gestational age 20-28 weeks at enrollment - Ability to read and write in English language - Planning to give birth at a healthcare facility & receive obstetrical care with a healthcare record - Reside within 20 minutes of the Lincoln/Omaha, NE metro area - Owns a smartphone with internet access Exclusion Criteria: - |
Country | Name | City | State |
---|---|---|---|
United States | University of Nebraska Medical Center | Omaha | Nebraska |
Lead Sponsor | Collaborator |
---|---|
University of Nebraska |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Nutritional Intake | Nutritional intake will be measured with the Multifactor Screener, 2000 as used in the Observing Protein and Energy Nutrition (OPEN) Study. This instrument measures approximate intakes of fruits and vegetables, percentage energy from fat, and fiber. Respondents report how frequently they consume foods in 16 categories and type of milk consumed. | Baseline, 6-12 weeks postpartum | |
Other | Physical Activity | Physical activity will be measured with the International Physical Activity Questionnaire short-form (IPAQ-SF). The IPAQ-SF consists of 9 items and provides information on the time spent walking, in vigorous and moderate intensity activity and in sedentary activity. | Baseline, 6-12 weeks postpartum | |
Other | Sleep quality | Sleep quality will be measured using the Pittsburgh Sleep Quality Index (PSQI. The PSQI is a self-report questionnaire that assesses sleep quality over a 1-month time interval. The measure consists of 19 individual items, creating 7 components that produce one global score. | Baseline, 6-12 weeks postpartum | |
Other | Healthcare Adherence | Healthcare adherence will be measured by number of healthcare appointments measured in the medical record. | Pregnancy continuum, measured at 12 weeks postpartum retrospectively via the medical record | |
Other | Self-efficacy | Self-efficacy will be measured using the GSE General Self Efficacy (GSE) Scale: The GSE is a one-dimensional self-report measure that features a 10-item questionnaire assessing the optimistic self-beliefs of individuals to cope with a variety of difficult demands in life. The response options are presented along a 4-point Likert scale for each item. | Baseline, 6-12 weeks postpartum | |
Other | Social support | Social support will be measured with the 10 item Social Provisions Scale (SPS-10). The SPS-10 assesses five forms of social provisions: attachment, guidance, social integration, reliable alliance, and reassurance of worth. Each item is rated on a four-point Likert scale. | Baseline, 6-12 weeks postpartum | |
Other | Problem-solving | Problem solving will be measured with the Problem-Solving Inventory (PSI). The PSI measures how well individuals make decisions and their problem-solving abilities. The PSI includes 32 items using a 6-point Likert scale. | Baseline, 6-12 weeks postpartum | |
Other | Motivation | Motivation will be measured with the Self-Motivation Inventory (SMI). The SMI is a 40 item 5 point Likert scale. | Baseline, 6-12 weeks postpartum | |
Other | Resilience | Resilience will be measured using the 10 item Connor-Davidson Resilience Scale (CD-RISC 10). The CD-RISC 10 a unidimensional self-reported scale consisting of 10-items measuring resilience. Respondents rate items on a 5-point Likert scale. | Baseline, 6-12 weeks postpartum | |
Other | Self-Regulation | Self-Regulation will be measured with the index of self-regulation (ISR). The ISR is a nine-item scale that measures level of self-regulation for health behavior change. Respondents rate items on a 5-point Likert scale. | Baseline, 6-12 weeks postpartum | |
Other | Discrimination | Discrimination will be measured using the Everyday Discrimination Scale (EDS). The EDS measures frequency of chronic and routine unfair treatment in everyday life. Respondents are asked to report how often they experience unfair treatment in their day-to-day life on a 6-point Likert scale. | Baseline, 6-12 weeks postpartum | |
Other | Neighborhood | Neighborhood will be assessed using the Neighborhood Collective Efficacy - Community Cohesion and Informal Social Control protocol. This protocol includes 10 Likert-style questions from the Project on Human Development in Chicago Neighborhoods (PHDCN). The Social Cohesion and Informal Social Control subscales include five items each. | Baseline | |
Other | Acceptability and Experience | Select intervention participants only (10-15). Qualitative interview to discuss acceptability and experience with the intervention. | 12 weeks postpartum | |
Primary | Maternal Blood Pressure | Participant blood pressure (systolic and diastolic) (continuous) as well as blood pressure classifications hypertension (>140/90); Severe hypertension (>160/110). | 20 weeks | |
Primary | Maternal Blood Pressure | Participant blood pressure (systolic and diastolic) (continuous) as well as blood pressure classifications hypertension (>140/90); Severe hypertension (>160/110). | 36 weeks | |
Primary | Maternal Blood Pressure | Participant blood pressure (systolic and diastolic) (continuous) as well as blood pressure classifications hypertension (>140/90); Severe hypertension (>160/110). | Birth (approximately 36-42 weeks) | |
Primary | Maternal Blood Pressure | Participant blood pressure (systolic and diastolic) (continuous) as well as blood pressure classifications hypertension (>140/90); Severe hypertension (>160/110). | 6-12 weeks postpartum | |
Primary | Feasibility, Enrollment | Percentage of eligible individuals who agree to participate in the trial | Baseline | |
Primary | Feasibility, Attrition | Percentage of eligible individuals who complete the data | Completion of Study (~24 months) | |
Primary | Feasibility, Adherence | Number of intervention sessions completed by study participants | Completion of Study (~24 months) | |
Secondary | Gestational Weight Gain | Amount of weight gained in pounds | 20 weeks, 36 weeks, Birth, 6 weeks postpartum. | |
Secondary | Delivery Modality | Modality of birth (Vaginal, Cesarean, Assisted Vaginal delivery) | Birth (approximately 36-42 weeks) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03255187 -
Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution
|
N/A | |
Completed |
NCT05997303 -
Continuous Norepinephrine Administration and Blood Pressure Stability During Anesthetic Induction
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT03918486 -
Caretaker vs. Routine Blood Pressure Sphygmomanometer
|
||
Completed |
NCT03410342 -
The Effects of Types of Fruits and Vegetables on Vascular Function
|
N/A | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT04087070 -
Blood Pressure Estimation Using Noninvasive Biosignals During Pediatric Anesthesia
|
||
Completed |
NCT03294928 -
Arterial Waveform Analysis Applying Different Positive End-Expiratory Pressure (PEEP) Levels in Healthy Volunteers
|
N/A | |
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Completed |
NCT03997461 -
Comparison of Arterial Tonometry Sensor With Standard Oscillometric Blood Pressure Monitoring Device
|
N/A | |
Completed |
NCT03290716 -
Diet, ExerCIse and carDiovascular hEalth (DECIDE) - Salt Reduction Strategies for the Elderly in Nursing Homes in China
|
N/A | |
Recruiting |
NCT06460233 -
Blood Pressure Changes After Bariatric Surgery
|
||
Recruiting |
NCT05196048 -
Blood Pressure Sensor of Watch-type Device With ECG Technology
|
||
Terminated |
NCT03325933 -
Resistance Training and Cardiometabolic Health
|
N/A | |
Not yet recruiting |
NCT06405880 -
Pharmacist Case Finding and Intervention for Vascular Prevention Trial
|
N/A | |
Completed |
NCT02924454 -
Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol.
|
Phase 4 | |
Completed |
NCT02451059 -
Reducing Socioeconomic Disparities in Health at Pediatric Visits
|
N/A | |
Active, not recruiting |
NCT02670967 -
Effects of Soluble Fiber on Blood Pressure: A Meta-analysis of Randomly-controlled Trials
|
N/A | |
Completed |
NCT02271633 -
Nitrate Supplementation; Source
|
Phase 4 | |
Completed |
NCT02239744 -
Intervention Study on the Health Impact of Air Filters in Chinese Adults
|
N/A |